ADK:CA Diagnos Inc

CAD 0.24 0.00 0
Icon

Diagnos Inc (ADK:CA) Stock Analysis and Price Targets

COMMON STOCK | Health Information Services | TSV
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

CAD 0.235

0.00 (0.00)%

CAD 0.02B

0.09M

CAD 1.13(+378.72%)

CAD 1.08 (+359.57%)

Icon

ADK:CA

Diagnos Inc (CAD)
COMMON STOCK | TSV
CAD 0.24
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

CAD 0.02B

CAD 1.08 (+359.57%)

CAD 0.24

Diagnos Inc (ADK:CA) Stock Forecast

CAD 1.13
(+378.72%)

Based on the Diagnos Inc stock forecast from 2 analysts, the average analyst target price for Diagnos Inc is CAD 1.13 over the next 12 months. Diagnos Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Diagnos Inc is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, Diagnos Inc’s stock price was CAD 0.235. Diagnos Inc’s stock price has changed by -6.00% over the past week, -16.07% over the past month and -33.80% over the last year.

No recent analyst target price found for Diagnos Inc
No recent average analyst rating found for Diagnos Inc

Company Overview Diagnos Inc

DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare profess...Read More

N/A

N/A

0

N/A

CAD

Canada

Adjusted Closing Price for Diagnos Inc (ADK:CA)

Loading...

Unadjusted Closing Price for Diagnos Inc (ADK:CA)

Loading...

Share Trading Volume for Diagnos Inc Shares

Loading...

Compare Performance of Diagnos Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ADK:CA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Diagnos Inc (Sector: Health Information Services )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
RHT:CA
Reliq Health Technologies Inc 0.00 (0.00%) CAD0.05B N/A -10.78

ETFs Containing ADK:CA

Symbol Name ADK:CA's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Diagnos Inc (ADK:CA) Stock

Based on ratings from 2 analysts Diagnos Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 4 buy, sell and 1 hold ratings.

Unfortunately we do not have enough data on ADK:CA's stock to indicate if its a good dividend stock.

Based on targets from 2 analysts, the average taret price for ADK:CA is CAD 1.13 over the next 12 months. The maximum analyst target price is CAD 1.5 while the minimum anlayst target price is CAD 0.5.

Unfortunately we do not have enough data on ADK:CA's stock to indicate if its overvalued.

The last closing price of ADK:CA's stock was CAD 0.24.

The most recent market capitalization for ADK:CA is CAD 0.02B.

Based on targets from 2 analysts, the average taret price for ADK:CA is projected at CAD 1.13 over the next 12 months. This means that ADK:CA's stock price may go up by +378.72% over the next 12 months.

We can't find any ETFs which contains Diagnos Inc's stock.

As per our most recent records Diagnos Inc has 0 Employees.

Sorry we do not have any infomation available on Diagnos Inc's address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...